Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $37.73B | $340.61 | $390.88 | 14.76% | Strong Buy | 8 | 120.85% | 374.05% | 3,252.07% | 1,759.41% | |||
| CORT | CORCEPT THERAPEUTICS INC | $8.35B | $79.40 | $135.33 | 70.44% | Strong Buy | 3 | 29.21% | 71.83% | 137.93% | 105.82% | |||
| NVO | NOVO NORDISK A S | $219.29B | $49.35 | $57.40 | 16.31% | Buy | 5 | 94.27% | 97.06% | 481.51% | 159.69% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $59.61B | $451.23 | $496.59 | 10.05% | Strong Buy | 24 | 27.95% | 234.94% | 1,231.98% | 59.39% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $140.74M | $1.75 | $12.00 | 585.71% | Buy | 1 | 33.60% | 195.08% | 176.55% | 113.55% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $484.16M | $8.60 | $23.00 | 167.44% | Strong Buy | 4 | 43.39% | 47.41% | 113.63% | 56.02% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.22B | $42.52 | $51.33 | 20.73% | Strong Buy | 6 | 20.29% | 66.99% | 41.88% | 31.47% | |||
| VCEL | VERICEL CORP | $2.04B | $40.25 | $58.33 | 44.93% | Strong Buy | 3 | 17.30% | 59.36% | 27.97% | 19.86% | |||
| ARGX | ARGENX SE | $55.66B | $911.98 | $960.08 | 5.27% | Strong Buy | 13 | 1,432.04% | 11.94% | 43.41% | 36.87% | |||
| RPRX | ROYALTY PHARMA PLC | $23.10B | $40.02 | $46.00 | 14.94% | Strong Buy | 3 | 12.40% | 47.82% | 41.62% | 20.69% | |||
| TECH | BIO-TECHNE CORP | $10.05B | $64.51 | $70.80 | 9.75% | Strong Buy | 10 | 6.38% | 72.51% | 20.45% | 15.91% | |||
| GMAB | GENMAB A | $20.78B | $32.36 | $43.75 | 35.20% | Strong Buy | 4 | 11.23% | 115.38% | 34.97% | 28.64% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $4.00B | $203.18 | $233.75 | 15.05% | Strong Buy | 4 | 4.78% | 55.67% | 23.49% | 15.12% | |||
| KRYS | KRYSTAL BIOTECH INC | $6.32B | $218.00 | $213.17 | -2.22% | Buy | 6 | 29.98% | 16.97% | 44.02% | 40.39% | |||
| GYRE | GYRE THERAPEUTICS INC | $746.58M | $7.75 | $17.00 | 119.35% | Strong Buy | 2 | 14.35% | 17.03% | 218.85% | 139.94% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.40B | $71.40 | $77.13 | 8.02% | Buy | 8 | 16.43% | 26.49% | 241.37% | 54.76% | |||
| VCYT | VERACYTE INC | $3.74B | $47.34 | $44.17 | -6.70% | Buy | 6 | 7.53% | 45.50% | 13.77% | 12.66% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.74B | $55.93 | $87.10 | 55.73% | Strong Buy | 10 | 6.52% | 25.68% | 22.03% | 17.52% | |||
| CRMD | CORMEDIX INC | $772.92M | $9.81 | $18.40 | 87.56% | Buy | 5 | 27.53% | 3.95% | 64.44% | 32.11% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.13B | $16.12 | $17.67 | 9.60% | Buy | 3 | 11.00% | 17.33% | 46.60% | 32.31% | |||
| INVA | INNOVIVA INC | $1.62B | $21.73 | $32.00 | 47.26% | Buy | 4 | 6.99% | 10.15% | 20.54% | 14.52% | |||
| INCY | INCYTE CORP | $20.51B | $104.46 | $93.80 | -10.20% | Buy | 15 | 8.31% | 14.06% | 43.11% | 31.67% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.03B | $35.29 | $46.29 | 31.16% | Strong Buy | 7 | 11.03% | 17.26% | 69.43% | 47.99% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $110.02B | $433.61 | $480.05 | 10.71% | Buy | 19 | 7.51% | 16.73% | 36.72% | 25.58% | |||
| ADMA | ADMA BIOLOGICS INC | $4.56B | $19.18 | N/A | N/A | N/A | N/A | 19.43% | 12.65% | 94.87% | 71.93% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $540.29M | $6.77 | $16.33 | 141.26% | Strong Buy | 3 | 13.66% | 7.24% | 72.56% | 52.26% | |||
| EXEL | EXELIXIS INC | $11.84B | $44.17 | $45.59 | 3.21% | Buy | 17 | 9.96% | 14.04% | 58.25% | 44.57% | |||
| UTHR | UNITED THERAPEUTICS CORP | $20.93B | $486.00 | $495.08 | 1.87% | Buy | 12 | 5.75% | 2.59% | 24.64% | 22.09% | |||
| MNKD | MANNKIND CORP | $1.64B | $5.35 | $10.08 | 88.47% | Strong Buy | 6 | 11.75% | 18.57% | -326.91% | 29.44% | |||
| MDXG | MIMEDX GROUP INC | $1.02B | $6.88 | $12.00 | 74.42% | Strong Buy | 1 | 5.78% | 14.58% | N/A | N/A | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.88B | $23.41 | $33.00 | 40.97% | Strong Buy | 1 | 5.30% | 0.59% | 49.18% | 43.04% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $82.00B | $780.19 | $760.47 | -2.53% | Strong Buy | 17 | 4.92% | 5.91% | 19.10% | 14.72% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.